<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../figures/favicon.png" type="image/x-icon">
  <title>Postpartum Hemorrhage; Prevention and Treatment</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="/about-temp2.html">About</a>
      </li>
      
     
      

      <!-- <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Pediatrics</a>
          </li>
        </ul>
      </li> -->
    </ul>
  </nav>
  
  <main class="page-container">
    <!-- <div class="contribute-cta">
      <p>Help make this betterðŸ’œ</p>
      <span><a href="/contribute.html">Contribute here</a> </span>
    </div> -->

    <h1>Postpartum Hemorrhage; Prevention and Treatment</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction </a></li>
            <li><a href="#header-2">Clinical relevance</a></li>
            <li><a href="#header-3">Primary postpartum hemorrhage</a></li>
            <ul>
                <li><a href="#heading-3-1">	Causes </a></li>
                <li><a href="#heading-3-2">	Risk factors</a></li>
                <li><a href="#heading-3-3">	Presentation</a></li>
                <li><a href="#heading-3-4">	Investigations</a></li>
                <li><a href="#heading-3-5">	Prevention </a></li>
                <li><a href="#heading-3-6">	Treatment</a></li>
            </ul>
            <li><a href="#header-4">Secondary Postpartum Hemorrhage</a></li>
            <ul>
                <li><a href="#heading-3-1">	Causes</a></li>
                <li><a href="#heading-3-2">	Clinical features</a></li>
                <li><a href="#heading-3-3">	Management</a></li>
            </ul>
            <li><a href="#header-5">Conclusion</a></li>
            
         </ol>
        </div>
      </label>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction </a>
          </h2>
        </header>
        <div class='body'>
            <p>Postpartum hemorrhage is an obstetric emergency, which if not well managed can lead to maternal mortality or significant morbidity.</p>
            <p>It can either be primary or secondary</p>
            <p>It is one of the leading cause of maternal mortality and morbidity</p>
        </div>

        <h4><span class="special-text-4">Primary postpartum hemorrhage </span></h4>
        <p>Can be defined as</p>
        <ol>
            <li>Bleeding from the genital tract of 500mls or more within the first 24hours of delivery following a vaginal delivery</li>
            <li>Bleeding from the genital tract of 1000mls or more within the first 24hours of delivery following a caesarean delivery.</li>
            <li>Bleeding from the genital tract that cause a decrease of hematocrit by 10% or more within the first 24 hours of delivery</li>
            <li>Any degree of bleeding from the genital tract within the first 24hours of delivery that is significant enough to affect the hemodynamic stability of a woman.</li>
        </ol>

        <h4><span class="special-text-4">Secondary postpartum hemorrhage </span></h4>
        <p>Can be defined as abnormal bleeding from the genital tract, occurring 24 hours after delivery until 6 weeks postpartum.</p>
        <p>It usually causes moderate bleeding postpartum, though it can also cause life threatening bleeds.</p>
        <p>It is usually as a result of postpartum endometritis (uterine infection) or retained products of conception</p>
        <p>Some people believe that the postpartum period extend to 12 weeks post delivery</p>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Clinical Relevance</a>
          </h2>
        </header>
        <div class='body'>
            <p>Uterine blood flow reaches 600 mL/minute near term, subjecting the pregnant patient to the risk of devastating blood loss.</p>
            <p>10% of maternal death in all deliveries</p>
            <p>1% case fatality rate </p>
            <p>45% of maternal death in postpartum period occur in the first 24 hours.</p>
            <p>2/3 of women with PPH have no identifiable clinical risk factor.</p>
            <p>Nigeria is the country where nearly 20% of all global maternal deaths happen.</p>
            <p>In 2015, Nigeriaâ€™s estimated maternal mortality ratio was over 800 maternal deaths per 100 000 live births, with approximately 58 000 maternal deaths during that year. </p>
            <p>In fact, a Nigerian woman has a 1 in 22 lifetime risk of dying during pregnancy, childbirth or postpartum/post-abortion; whereas in the most developed countries, the lifetime risk is 1 in 4900.</p>
            <p>By comparison, the total number of maternal deaths in 2015 in the 46 most developed countries was 1700, resulting in a maternal mortality ratio of 12 maternal deaths per 100 000 live births.</p>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Primary Postpartum Hemorrhage</a>
          </h2>
        </header>
        <div class='body'>

            <section id='heading-3-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-1'>Causes</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4><span class="special-text-4">THE FOUR Ts   </span></h4>
                    <ul>
                        <li>Tone: Atonic uterus</li>
                        <li>Trauma: Cervical, vaginal and perineal lacerations, pelvic hematomas, uterine inversion, ruptured uterus</li>
                        <li>Tissue: Retained tissue (placental fragments and/or membranes), invasive placenta</li>
                        <li>Thrombin: Coagulopathies from e.g. Von Willebrandâ€™s disease, platelet disorders, consumptive coagulopathy.</li>
                    </ul>
                </div>
            </section>

            <section id='heading-3-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-2'>Risk Factors</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4><span class="special-text-4b">Risk factors for development of uterine atony are as follows:</span></h4>
                    <ul>
                        <li>Overdistension of uterus (multiple gestation, polyhydraminous,fetal macrosomia)</li>
                        <li>Induction of labor</li>
                        <li>Prolonged/precipitate labor</li>
                        <li>Anesthesia (halogenated drugs like halothane) and</li>
                        <li>Analgesia</li>
                        <li>Tocolytics (nifedipine, magnesium, beta-mimetics, indomethacin,nitirc oxide donors)</li>
                        <li>Grand multiparity</li>
                        <li>Mismanagement of 3rd stage of labor</li>
                        <li>Full bladder</li>
                        <li>Antepartum hemorrhage (placenta previa, abruption placenta, couvelaire uterus, etc)</li>
                        <li>Prolonged labor</li>
                        <li>Chorioamnionitis</li>
                        <li>Dystocia</li>
                    </ul>

                    <h4><span class="special-text-4">Risk factors for PPH due to tissues</span></h4>
                    <ul>
                        <li>Retained bits of placental tissue</li>
                        <li>Blood clots that remain inside the uterine cavity and are not expelled out. </li>
                        <li>Invasive placenta refers to abnormal adherence of the placenta to the uterine wall due to invasion of the uterine wall by the placental trophoblasts. </li>
                        <li>Adherent placenta can be of three types: Placenta accreta; placenta increta and placenta percreta.</li>
                    </ul>

                    <h4><span class="special-text-4">Traumatic causes for PPH are as follows:</span></h4>
                    <ul>
                        <li>Large episiotomy and extensions</li>
                        <li>Tears and lacerations of perineum, vagina or cervix</li>
                        <li>Pelvic hematomas</li>
                        <li>Uterine inversion</li>
                        <li>Ruptured uterus</li>
                    </ul>

                    <h4><span class="special-text-4">Risk Factor for PPH Due To Thrombin (Coagulopathy)</span></h4>
                    <ul>
                        <li>Acquired during pregnancy: thrombocytopenia of HELLP syndrome, DIC (eclampsia, intrauterine fetal death, septicemia, placenta abruptio, amniotic fluid embolism), pregnancy-induced hypertension, sepsis</li>
                        <li>Hereditary: Von Willebrandâ€™s disease</li>
                        <li>Anticoagulant therapy: valve replacement, patients on absolute bed rest</li>
                    </ul>

                    <h4><span class="special-text-4">Other risk factors that should be elucidated when taking history</span></h4>
                    <ul>
                        <li>Past history of PPH or retained placenta or manual removal of placenta</li>
                        <li>Operative delivery (use of forceps, ventouse etc.)</li>
                        <li>Delivery of a large placenta (e.g. due to multifetal gestation)</li>
                        <li>It is usually dramatic and can occur rapidly</li>
                        <li>Bleeding PV</li>
                        <li>Sweating and restlessness</li>
                        <li>Pallor</li>
                        <li>Rapid and thready pulse</li>
                        <li>Low BP</li>
                        <li>?uterine contraction</li>
                        <li>Bleeding may be slower, but may still ultimately result in critical loss and shock</li>
                        <li>There may be no obvious bleeding PV, but patient present with feature of shock</li>
                    </ul>

                </div>
            </section>

            <section id='heading-3-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-3'>Presentation</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>There may be no obvious bleeding PV, but patient present with feature of shock (uterine inversion, broad ligament hematomas, vaginal hematomas)</p>
                </div>
            </section>

            <section id='heading-3-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-4'>Investigations</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>CBC (including absolute platelet count)</p>
                   <p>Grouping & crossmatching (if severe, O negative uncrossmatched blood may be requested for) </p>
                   <p>Bed side clotting time</p>
                   <p>Clotting test (PT, PTTK and Fibrinogen level)</p>
                   <p>Serum U/E Cr and blood gas analysis.</p>
                </div>
            </section>

            <section id='heading-3-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-5'>Prevention</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Preconception: Family planning, treatment of anemia</p>
                   <p>Antenatal: Quality antenatal care</p>
                   <p>Intrapartum: Active management of labor</p>
                   <p>Postpartum: </p>
                   <ul>
                    <li>Active management of third stage of labor.</li>
                    <li>Early identification of risk factors</li>
                    <li>Active management of 3rd stage of labor</li>
                    <li>Oxytocin infusion of 20IU in 500ml infusion fluid post delivery</li>
                    <li>Use of prophylaxis dose of misoprostol (600Âµg)</li>
                    <li>Prompt repair of genital tract laceration</li>
                    <li>Continue uterine massage in the 1st 2hrs postpartum</li>
                   </ul>

                   <h4><span class="special-text-4">Prevention based on the delay model</span></h4>
                   <p>These identifies three groups of factors which may stop women and girls from accessing the maternal health they need.</p>
                   <ul>
                    <li>Primary delay (At home) â€” delay in decision to seek care</li>
                    <li>Secondary delay (Before presentation at health facility) â€” delay in reaching care</li>
                    <li>Tertiary delay (At health facility) â€” delay in receiving adequate care</li>
                   </ul>
                   <p>Provide 24 hour obstetric care</p>
                   <p>Upgrade the quality of care at health facilities</p>
                   <p>Ensure adequate stocks of medical supplies and blood</p>
                   <p>Enhance referral systems between communities and health facilities</p>
                   <p>Establish national protocols to treat obstetric complications</p>
                </div>
            </section>

            <section id='heading-3-6'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-6'>Treatment</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4><span class="special-text-4">â€˜Haemostasisâ€™</span></h4>
                    <p>Mnemonic that stands for</p>
                    <ul>
                        <li>Help</li>
                        <li>Access/Assess</li>
                        <li>Etiology/Empty bladder</li>
                        <li>Massage</li>
                        <li>Oxytocics</li>
                        <li>Shift (EUA plus repair, placenta removal)</li>
                        <li>Tamponade</li>
                        <li>Arterial ligation</li>
                        <li>Sutures</li>
                        <li>Interventional radiography (angiographic embolization)</li>
                        <li>Subtotal/Total-Hysterectomy</li>
                    </ul>

                    <h4><span class="special-text-4">Principles of management</span></h4>
                    <ul>
                        <li>Resuscitative measures</li>
                        <li>Medical treatment</li>
                        <li>Surgical treatment</li>
                        <li>Monitoring</li>
                    </ul>

                    <h4><span class="special-text-4b">Medical treatment</span></h4>
                    <ul>
                        <li>Syntocinon/Oxytocin 10/40IU</li>
                        <li>Syntometrin(0.5mg/5iu)</li>
                        <li>Ergometrin (0.2-0.25mg)</li>
                        <li>Misoprostol-1000Âµg</li>
                        <li>Carboprost (15-methyl PGF2Î±) 250 Î¼g given as intramuscular injection every 15 minutes for a maximum of eight doses</li>
                        <li>Recombinant Factor VIIa (rFVIIa) 40-60Âµg/kg</li>
                    </ul>

                    <h4><span class="special-text-4">Other treatment modalities</span></h4>
                    <ul>
                        <li>Non-pneumatic anti-shock garment</li>
                        <figure>
                            <img src="/figures/pph (4).png" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>Sengstakenâ€“Blakemore tube</li>
                        <figure>
                            <img src="/figures/pph (2).png" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li> Bakri hydrostatic balloon catheter</li>
                        <figure>
                            <img src="/figures/pph (1).png" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>Bimanual uterine compression</li>
                        <figure>
                            <img src="/figures/pph (1).jpg" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>Artery ligation</li>
                        <figure>
                            <img src="/figures/pph (2).jpg" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>B-LYNCH</li>
                        <figure>
                            <img src="/figures/pph (3).png" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>Interventional radiography</li>
                        <figure>
                            <img src="/figures/pph (2).jpeg" alt="">
                            <figcaption> </figcaption>
                           </figure>
                        <li>Subtotal and total hysterectomy</li>
                        <figure>
                            <img src="/figures/pph (1).gif" alt="">
                            <figcaption> </figcaption>
                           </figure>
                    </ul>

                    <figure>
                        <img src="/figures/pph (1).jpeg" alt="">
                        <figcaption>PPH management </figcaption>
                       </figure>

                </div>
            </section>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Secondary Postpartum Hemorrhage</a>
          </h2>
        </header>
        <div class='body'>
            <section id='heading-4-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1'>Causes</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>Placental/fetal membrane retention</li>
                    <li>Infection (puerperal sepsis) </li>
                    <li>Unidentified / silent uterine rupture</li>
                    <li>DIC</li>
                   </ul>
                </div>
            </section>

            <section id='heading-4-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-2'>Clinical features </a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>Bleeding PV</li>
                    <li>Fever</li>
                    <li>Feeling of unwell (malaise)</li>
                    <li>Uterine subinvolution</li>
                    <li>Offensive vaginal discharge</li>
                   </ul>
                </div>
            </section>

            <section id='heading-4-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-3'>Management</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Evaluation</p>
                   <p>Clinical history</p>
                   <p>Examination</p>
                   <p>Investigation</p>
                   <ul>
                    <li>Blood</li>
                    <li>Sepsis screening</li>
                    <li>USS</li>
                   </ul>
                   <p>Treatment</p>
                   <ul>
                    <li>Antibiotic cover</li>
                    <li>Evacuation of retained products</li>
                    <li>Blood transfusion</li>
                   </ul>
                </div>
            </section>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Conclusion</a>
          </h2>
        </header>
        <div class='body'>
            <p>Nigeria is a major contributor to maternal mortality statistics worldwide, and the leading cause of maternal mortality in this environment remains hemorrhage, thus all efforts must be made to prevent and treat postpartum hemorrhage, so that the journey of child-birth for our women will not be a journey to the great beyond.</p>
        </div>
      </section>


      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <!-- <p>Send us a <a href="mailto:obgyn.materia@gmail.com"><span class="special-text-2">mail</span></a> at 
         <br> obgyn.materia@gmail.com.</p>
        <p>Or send your comments, corrections, explanations/clarifications and requests/suggestions to our 
         <br> <a href="" class="special-text-2" style="text-decoration: none;">WhatsApp group</a>.</p> -->
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia.[beta]</p>
          
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="/main.js"></script>
</body>
</html>
 
